Agios Pharmaceuticals AGIO
NASDAQ AGIO
$37.18 +0.54 (+1.47%)
At close: Oct 21, 2026 · 4:00 PM EDT

Agios Pharmaceuticals (AGIO) Non-Current Assets (2012 - 2026)

Updated

Agios Pharmaceuticals (AGIO) posted Non-Current Assets of $390.76 million for Q2 2026, down 13.5% from $451.77 million a year earlier but up 11.6% from the prior quarter.

Analysis

Agios Pharmaceuticals (AGIO) Non-Current Assets (2012 - 2026) Analysis & Trends

At the end of FY2025, Agios Pharmaceuticals' Non-Current Assets came in at $355.17 million, down 49.1% from FY2024.

  • Annual Non-Current Assets shows a five-year compound annual growth rate of 10.4% (FY2020 to FY2025).
  • In prior years, Agios Pharmaceuticals' Non-Current Assets was $697.6 million in FY2024 (+575.4%), $103.28 million in FY2023 (-74.6%), $405.95 million in FY2022 (+8.7%) and $373.51 million in FY2021 (+72.7%).
  • Quarterly Non-Current Assets has run from a low of $103.28 million in Q4 2023 to a high of $717.61 million in Q3 2024 over five years.
  • On a year-over-year basis, Non-Current Assets has declined in each of the last four quarters, with growth averaging 124.3% over the last eight quarters.
  • The strongest year-over-year quarter for Non-Current Assets in the past five years was Q4 2024, with growth of 575.4%; the weakest was Q4 2023, with a decline of 74.6%.
  • According to Business Quant data, Non-Current Assets for the three prior quarters was $350.15 million (Q1 2026), $355.17 million (Q4 2025) and $352.6 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 77.61 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 141.29 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 101.45 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 125.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 94.68 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 87.87 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 60.68 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 35.42 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 159.77 Bn
10 Agios Pharmaceuticals 2.22 Bn -943.26 Mn 41.75 Mn 390.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 390.76 Mn
Mar 31, 2026 350.15 Mn
Dec 31, 2025 355.17 Mn
Sep 30, 2025 352.60 Mn
Jun 30, 2025 451.77 Mn
Mar 31, 2025 586.90 Mn
Dec 31, 2024 697.60 Mn
Sep 30, 2024 717.61 Mn
Jun 30, 2024 140.94 Mn
Mar 31, 2024 186.08 Mn
Dec 31, 2023 103.28 Mn
Sep 30, 2023 302.91 Mn
Jun 30, 2023 327.91 Mn
Mar 31, 2023 359.64 Mn
Dec 31, 2022 405.95 Mn
Sep 30, 2022 395.39 Mn
Jun 30, 2022 382.46 Mn
Mar 31, 2022 360.71 Mn
Dec 31, 2021 373.51 Mn
Sep 30, 2021 236.21 Mn
API Access

Agios Pharmaceuticals Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=AGIO&period=max&api_key=YOUR_API_KEY